These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 28729047)

  • 1. P53 deregulation in Epstein-Barr virus-associated gastric cancer.
    Ribeiro J; Malta M; Galaghar A; Silva F; Afonso LP; Medeiros R; Sousa H
    Cancer Lett; 2017 Sep; 404():37-43. PubMed ID: 28729047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Significance of the expression of P53 protein and P21WAF1 protein in the gastric carcinoma tissues associated with Epstein-Barr virus (EBV) infections].
    Qian J; Li DQ; Zhong F; Li ZX; Lu LC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):1-3. PubMed ID: 16642206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between Epstein-Barr virus-encoded proteins with cell proliferation, apoptosis, and apoptosis-related proteins in gastric carcinoma.
    Wang Y; Luo B; Yan LP; Huang BH; Zhao P
    World J Gastroenterol; 2005 Jun; 11(21):3234-9. PubMed ID: 15929173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of single nucleotide polymorphism rs2065955 of the filaggrin gene with susceptibility to Epstein-Barr virus-associated gastric carcinoma and EBV-negative gastric carcinoma.
    Kuang X; Sun L; Liu S; Zhao Z; Zhao D; Liu S; Luo B
    Virol Sin; 2016 Aug; 31(4):306-13. PubMed ID: 27535066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
    Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P
    World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
    Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
    Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glypican-4 gene polymorphism (rs1048369) and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma.
    Zhao D; Liu S; Sun L; Zhao Z; Liu S; Kuang X; Shu J; Luo B
    Virus Res; 2016 Jul; 220():52-6. PubMed ID: 27071854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deregulation of immune response genes in patients with Epstein-Barr virus-associated gastric cancer and outcomes.
    Kim SY; Park C; Kim HJ; Park J; Hwang J; Kim JI; Choi MG; Kim S; Kim KM; Kang MS
    Gastroenterology; 2015 Jan; 148(1):137-147.e9. PubMed ID: 25254613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latent membrane protein 2A suppresses the expression of HER2 via a pathway involving TWIST and YB-1 in Epstein-Barr virus-associated gastric carcinomas.
    Zhang YW; Zhao XX; Tan C; Zhang ZG; Jiang Y; Chen JN; Wei HB; Xue L; Li HG; Du H; Shao CK
    Oncotarget; 2015 Jan; 6(1):207-20. PubMed ID: 25402957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation of E-cadherin and its abnormal expression in Epstein-Barr virus-associated gastric carcinoma.
    Sudo M; Chong JM; Sakuma K; Ushiku T; Uozaki H; Nagai H; Funata N; Matsumoto Y; Fukayama M
    Int J Cancer; 2004 Mar; 109(2):194-9. PubMed ID: 14750169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus miR-BART3-3p promotes tumorigenesis by regulating the senescence pathway in gastric cancer.
    Wang J; Zheng X; Qin Z; Wei L; Lu Y; Peng Q; Gao Y; Zhang X; Zhang X; Li Z; Fu Y; Liu P; Liu C; Yan Q; Xiong W; Li G; Lu J; Ma J
    J Biol Chem; 2019 Mar; 294(13):4854-4866. PubMed ID: 30674552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation of Fas/FasL expression to cell apoptosis in Epstein-Barr virus-associated gastric carcinoma.
    He D; Xiao L; Chen JN; Liang Q; Shao CK
    Chin J Cancer; 2010 Mar; 29(3):283-7. PubMed ID: 20193111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and prognosis of Epstein-Barr virus-associated gastric cancer.
    Li LL; Yu AY; Zhu M; Ma LY; Cao MH; Liu WL; Qin XB; Gao C; Han ZX; Wang HM
    Arch Virol; 2024 May; 169(5):114. PubMed ID: 38700535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and molecular characteristics of Epstein-Barr virus-associated gastric carcinoma: a meta-analysis.
    Lee JH; Kim SH; Han SH; An JS; Lee ES; Kim YS
    J Gastroenterol Hepatol; 2009 Mar; 24(3):354-65. PubMed ID: 19335785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide analysis of Epstein-Barr virus (EBV) isolated from EBV-associated gastric carcinoma (EBVaGC).
    Liu Y; Yang W; Pan Y; Ji J; Lu Z; Ke Y
    Oncotarget; 2016 Jan; 7(4):4903-14. PubMed ID: 26716899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of CCL21 by EBV-associated gastric carcinoma cells protects CD8
    Tang F; Chen JN; Zhang NN; Gong LP; Jiang Y; Feng ZY; Xiao L; Li HG; Du H; Wu B; Shao CK
    Pathology; 2018 Oct; 50(6):613-621. PubMed ID: 30149990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of HER2 and downstream proteins in prediction of advanced tumor phenotypes and overall survival of patients with Epstein-Barr virus-positive vs. negative gastric cancers.
    Zhang YW; He D; Tan C; Dong M; Zhou L; Shao CK
    Pathol Res Pract; 2019 Nov; 215(11):152675. PubMed ID: 31594682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.